Home Applications 021515 Application 021515
Type NDA
Sponsor VALEANT INTL Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 WELLBUTRIN XL BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 150MG Yes No 002 WELLBUTRIN XL BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 300MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021515-001 WELLBUTRIN XL BUPROPION HYDROCHLORIDE 150MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD 2003-08-28 N021515-002 WELLBUTRIN XL BUPROPION HYDROCHLORIDE 300MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD, RS 2003-08-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N021515-001 WELLBUTRIN XL 150MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD 2003-08-28 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N021515-002 WELLBUTRIN XL 300MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD, RS 2003-08-28 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N021515-001 WELLBUTRIN XL 150MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD 2003-08-28 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N021515-002 WELLBUTRIN XL 300MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD, RS 2003-08-28 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N021515-001 WELLBUTRIN XL 150MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD 2003-08-28 e64feba35796…2022-09-29 23:25 UTC 2022-09 N021515-002 WELLBUTRIN XL 300MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD, RS 2003-08-28 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021515-001 WELLBUTRIN XL 150MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD 2003-08-28 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021515-002 WELLBUTRIN XL 300MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD, RS 2003-08-28 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021515-001 WELLBUTRIN XL 150MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD 2003-08-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021515-002 WELLBUTRIN XL 300MG TABLET, EXTENDED RELEASE / ORAL AB3 RLD, RS 2003-08-28 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 90 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 22 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0187-0730 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0730 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0730 WELLBUTRIN bupropion hydrochloride Bausch Health Americas, Inc. NDA Current 0187-0730 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0730 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0730 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0730 WELLBUTRIN bupropion hydrochloride Valeant Pharmaceuticals North America LLC NDA Current 0187-0730 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0730 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0730 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0731 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0731 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0731 WELLBUTRIN bupropion hydrochloride Bausch Health Americas, Inc. NDA Current 0187-0731 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0731 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0731 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0731 WELLBUTRIN bupropion hydrochloride Valeant Pharmaceuticals North America LLC NDA Current 0187-0731 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0731 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 0187-0731 WELLBUTRIN bupropion hydrochloride Bausch Health US LLC NDA Current 21695-137 WELLBUTRIN XL bupropion hydrochloride Rebel Distributors Corp NDA Current 21695-138 WELLBUTRIN XL bupropion hydrochloride Rebel Distributors Corp NDA Current